XTNT stockholders approve 12.3M share increase to 2023 equity plan at annual meeting

Xtant Medical Holdings, Inc.

12,300,000 additional shares approved for 2023 Equity Incentive Plan, effective immediately.
Six director nominees elected with over 79M votes for each; no changes to board composition.
Ratification of Grant Thornton as auditor for FY 2025; advisory vote on exec compensation approved.
Stockholders voted 78.7M for 'every one year' frequency for future say-on-pay votes.
Quorum of 69.2% (96.9M shares) present at meeting held Nov 7, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.